Skip to content

Apotheek Wullens: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Wullens

BE 0722.761.747
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€69,472
2024 · €44,290+€25,181
Equity
€241,067
2024 · €191,596+€49,472
Cash
€12,315
2024 · €7,154+€5,161
Balance sheet total
€460,799
2024 · €429,545+€31,254

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€31,610

    up €31,610 (+20.9%), from €151,069 to €182,679

    of which Other amounts receivable: +€38,812

  • Intangible fixed assets -€17,000

    down €17,000 (-25.0%), from €68,000 to €51,000

  • Stocks and contracts +€9,133

    up €9,133 (+4.6%), from €198,744 to €207,878

  • Cash +€5,161

    up €5,161 (+72.1%), from €7,154 to €12,315

    mainly Net result for the year (+€69,472) and Other debts (+€20,000)

Equity and liabilities
  • Profit (loss) carried forward +€49,472

    up €49,472 (+26,037,637%), from €0 to €49,472

  • Trade debts -€38,997

    down €38,997 (-23.4%), from €166,738 to €127,741

  • Other debts +€20,000

    new in 2025: €20,000

  • Tax, wage and social debts +€18,586

    up €18,586 (+784%), from €2,370 to €20,956

  • Short-term financial debts -€14,179

    down €14,179 (-26.4%), from €53,714 to €39,534

Income statement
  • Taxes -€14,214

    down €14,214 (-76.1%), from €18,687 to €4,473

  • Gross operating margin +€6,216

    up €6,216 (+6.6%), from €94,583 to €100,799

  • Financial charges -€5,254

    down €5,254 (-44.6%), from €11,785 to €6,532

  • Financial income +€1,486

    up €1,486 (+6,531%), from €23 to €1,509

  • Other operating charges +€1,150

    up €1,150 (+65.3%), from €1,761 to €2,911

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €44,290
Gross operating margin +€6,216
Staff costs -€281
Depreciation -€558
Other operating charges -€1,150
Financial income +€1,486
Financial charges +€5,254
Taxes +€14,214
Result 2025 €69,472
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€50,991
Investment -€4,776
Financing -€41,055
Cash 2024 €7,154
Net result for the year +€69,472
Depreciation +€18,640
Stocks and contracts -€9,133
Receivables within one year -€31,610
Deferred charges and accrued income +€786
Trade debts -€38,997
Tax, wage and social debts +€18,586
Other debts +€20,000
Accrued charges and deferred income +€3,249
Investment in fixed assets (net) -€4,776
Current portion of long-term debt -€6,875
Short-term financial debts -€14,179
Contributions, distributions and other -€20,000
Cash 2025 €12,315
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €429,545 €460,799 +€31,254 +7.3%
Fixed assets 21/28 €70,451 €56,587 -€13,864 -19.7%
Intangible fixed assets 21 €68,000 €51,000 -€17,000 -25.0%
Tangible fixed assets 22/27 €2,451 €5,587 +€3,136 +128%
Plant, machinery and equipment 23 - €2,353 +€2,353
Furniture and vehicles 24 €2,451 €3,233 +€783 +31.9%
Current assets 29/58 €359,094 €404,212 +€45,118 +12.6%
Stocks and contracts in progress 3 €198,744 €207,878 +€9,133 +4.6%
Stocks 30/36 €198,744 €207,878 +€9,133 +4.6%
Amounts receivable within one year 40/41 €151,069 €182,679 +€31,610 +20.9%
Trade receivables 40 €60,927 €53,725 -€7,201 -11.8%
Other amounts receivable 41 €90,142 €128,954 +€38,812 +43.1%
Cash at bank and in hand 54/58 €7,154 €12,315 +€5,161 +72.1%
Deferred charges and accrued income 490/1 €2,127 €1,341 -€786 -36.9%
Total equity and liabilities 10/49 €429,545 €460,799 +€31,254 +7.3%
Equity 10/15 €191,596 €241,067 +€49,472 +25.8%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €179,196 €179,196 = 0.0%
Distributable reserves 133 €179,196 €179,196 = 0.0%
Profit (loss) carried forward 14 €0 €49,472 +€49,472 +26,037,637%
Amounts payable 17/49 €237,949 €219,732 -€18,217 -7.7%
Amounts payable within one year 42/48 €237,949 €216,483 -€21,466 -9.0%
Current portion of amounts payable after more than one year 42 €15,127 €8,252 -€6,875 -45.4%
Financial debts 43 €53,714 €39,534 -€14,179 -26.4%
Credit institutions 430/8 €53,714 €39,534 -€14,179 -26.4%
Trade debts 44 €166,738 €127,741 -€38,997 -23.4%
Suppliers 440/4 €166,738 €127,741 -€38,997 -23.4%
Taxes, remuneration and social security 45 €2,370 €20,956 +€18,586 +784%
Taxes 450/3 €2,370 €20,956 +€18,586 +784%
Other amounts payable 47/48 - €20,000 +€20,000
Accrued charges and deferred income 492/3 - €3,249 +€3,249
Remuneration, social security and pensions 62 - €281 +€281
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,082 €18,640 +€558 +3.1%
Other operating charges 640/8 €1,761 €2,911 +€1,150 +65.3%
Gross operating margin 9900 €94,583 €100,799 +€6,216 +6.6%
Operating profit (loss) 9901 €74,740 €78,967 +€4,227 +5.7%
Financial income 75/76B €23 €1,509 +€1,486 +6,531%
Recurring financial income 75 €23 €1,509 +€1,486 +6,531%
Financial charges 65/66B €11,785 €6,532 -€5,254 -44.6%
Recurring financial charges 65 €11,785 €6,532 -€5,254 -44.6%
Profit (loss) for the period before taxes 9903 €62,977 €73,944 +€10,967 +17.4%
Income taxes 67/77 €18,687 €4,473 -€14,214 -76.1%
Profit (loss) for the period 9904 €44,290 €69,472 +€25,181 +56.9%
Profit (loss) for the period to be appropriated 9905 €44,290 €69,472 +€25,181 +56.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.